CVS Health posted Q3 sales of $95.43 billion, driven by gains in Health Care Benefits. The company revised leadership roles and withdrew its 2024 guidance amid financial challenges.
CVS Health Stock Jumps After Mixed Q3 Earnings, Takes $1.2 Billion Restructuring Charges Hit
